CRISPR Therapeutics Announces the Appointment of Jon Terrett …NasdaqExperienced leader with extensive experience in immuno-oncology Dedicated unit in immuno-oncology to accelerate efforts. BASEL, Switzerland and.Hot Stocks Ratings: CRISPR Therapeutic… Continue reading
TheStreet.com |
Kite Pharma CAR–T Cancer Therapy Shows Strong, Durable Effect in Lymphoma Patients
TheStreet.com Kite Pharma’s (KITE) disclosed Tuesday six-month results from a pivotal study of its CAR–T therapy in patients with aggressive lymphomas that showed only a slight degradation in response rates and no new safety concerns compared to results previously … Kite’s CAR–T cancer therapy shows strong results as company races to win FDA approvalSTAT Kite Pharma’s cancer drug clears main goal in studyReuters Kite Pharma (KITE) Reports Positive Topline Data on Axicabtagene Ciloleucel from First Pivotal CAR–T Trial in …StreetInsider.com Endpoints News –Daily Mail all 44 news articles » |
Genetic Literacy Project |
CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and …
Yahoo Finance “We are thrilled to have Dr. Terrett join CRISPR to head up our immuno-oncology efforts,” commented Rodger Novak, CEO of CRISPR Therapeutics. “Given the potential of CRISPR/Cas9 gene editing in immuno-oncology, we have created a dedicated unit to … Who should own revolutionary gene editor CRISPR? Scientists or the public?Genetic Literacy Project Important decision from the USPTO in the field of genome engineeringLexology (registration) |
STAT |
Kite’s CAR–T cancer therapy shows strong results as company races to win FDA approval
STAT The treatment involves filtering a patient’s blood to remove key immune system soldiers called T–cells, altering them in the lab to contain a gene that targets cancer, and giving them back intravenously. Doctors call it a “living drug” — permanently … Kite Pharma (KITE) Reports Positive Topline Data on Axicabtagene Ciloleucel from First Pivotal CAR–T Trial in …StreetInsider.com Gene therapy to fight a blood cancer succeeds in major studyAtlanta Journal Constitution Ahead of Q4 Financials, Analysts are Upbeat about Kite Pharma …Economic Calendar |
Salon |
Gene therapy to fight a blood cancer succeeds in major study
Salon Gene therapy to fight a blood cancer succeeds in major study In this May 2016 photo provided by Kite Pharma, cell therapy specialists at the company’s manufacturing facility in El Segundo, Calif., prepare blood cells from a patient to be engineered in … |
|
Gene therapy to fight a blood cancer succeeds in major study
Washington Post An experimental gene therapy that turns a patient’s own blood cells into specialized cancer killers has passed a key test. Doctors announced Tuesday that more than one-third of very sick lymphoma patients who got the one-time treatment showed no sign … |